Home › Familial Amyloid Neuropathies › Missouri
Familial Amyloid Neuropathies clinical trials in Missouri
3 studies for Familial Amyloid Neuropathies are looking for participants at sites in Missouri.
Cities in Missouri
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Kansas City
- Research Site, St Louis
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- St. Luke's Hospital of Kansas City, Kansas City
- Washington University in St. Louis, St Louis
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Washington University in St. Louis, St Louis
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jul 29, 2026 · NCT07695701From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.